Precision Insights

Our mission is to provide market intelligence and strategic insights that drive disruption and innovation in the precision medicine and life science industry.

Contact US

Precision Insights

Our mission is to provide market intelligence and strategic vision to drive disruption and innovation in precision medicine.

Contact US
Latest Insights
Clinical Diagnostics
Where Multiplex Meets Digital Pathology – DeciBio’s Q&A with James Mansfield
Read the latest Q&A as our experts speak with James Mansfield, Senior VP, Research Business Development at Visiopharm to discuss the intersection of multiplex tissue analysis and digital pathology.
November 29, 2022
Clinical Diagnostics
Where Multiplex Meets Digital Pathology – DeciBio’s Q&A with James Mansfield
Read the latest Q&A as our experts speak with James Mansfield, Senior VP, Research Business Development at Visiopharm to discuss the intersection of multiplex tissue analysis and digital pathology.
November 29, 2022
Worldwide Spatial Biology market forecasted to grow at 30% p.a., reaching ~$1.2B by 2027 – Market Report by DeciBio Consulting
DeciBio released a Spatial Biology market report that summarizes the present and future (2022-2027) spatial biology products and services market landscape.
November 23, 2022
Worldwide Spatial Biology market forecasted to grow at 30% p.a., reaching ~$1.2B by 2027 – Market Report by DeciBio Consulting
DeciBio released a Spatial Biology market report that summarizes the present and future (2022-2027) spatial biology products and services market landscape.
November 23, 2022
Pharma & Biotech
The Broadening Use of siRNA in the Clinic: DeciBio's Q&A with June Park, CEO of siRNAgen Therapeutics
Read our lastest Q&A with June Park, CEO of siRNAgen, a novel RNAi platform spun out of Korea-based Bioneer
November 21, 2022
Pharma & Biotech
The Broadening Use of siRNA in the Clinic: DeciBio's Q&A with June Park, CEO of siRNAgen Therapeutics
Read our lastest Q&A with June Park, CEO of siRNAgen, a novel RNAi platform spun out of Korea-based Bioneer
November 21, 2022
Pharma & Biotech
AI’s Impact on the Clinical Pathology Lab: DeciBio's Q&A with Paige’s CEO Andy Moye
Check out our latest Q&A with Andy Moye of Paige, a company using a cloud-based AI Platform to help drive drug discovery and treatment for cancer.
November 8, 2022
Pharma & Biotech
AI’s Impact on the Clinical Pathology Lab: DeciBio's Q&A with Paige’s CEO Andy Moye
Check out our latest Q&A with Andy Moye of Paige, a company using a cloud-based AI Platform to help drive drug discovery and treatment for cancer.
November 8, 2022
View All Insights
Our Work

We work with leading diagnostic, research tools, pharmaceutical, biotech, and health technology companies to tackle challenging strategic questions.

Research Tools
Clinical Diagnostics
Pharma & Biotech
Financial Services

Strategy Consulting

We are experts at conducting strategic overhauls, new product expansions, and commercial due diligence.

Learn More about Us

Data & Platforms

Our team provides bottom-up data products and SaaS platforms, to facilitate decision-making.

VIew all Data & platforms
Client Results

Our Impact

We answer complex market questions regarding innovative technological applications.

See ALL Client Results
Pharma & Biotech
Biopharma Genomic Testing Market Research
A diagnostic company wanted to assess the current and expected future landscapes for biopharma oncology genomics research and Dx / CDx
Voice-Of-Customer Research
Biomarker and Diagnostic Strategy
Clinical Diagnostics
Minimal Residual Disease (MRD) Application Prioritization and Evidence Generation Strategy
A leader in ctDNA testing was interested in investigating the opportunity for their assay to support treatment decision-making in 2 tumor types of interest (including 6 cancer subtypes)
Application Identification
Go-to-Market Strategy
Research Tools
Methylation Analysis Opportunity Identification for Ultra-Sensitive Detection Platform
A leader in research tools and clinical diagnostic development asked us to evaluate the opportunity for an ultrasensitive detection platform in methylation analysis
Application Identification
Target Identification
Pharma & Biotech
Clinical, Genomic, and Pathology Real-World Data (RWD) Market Landscape Assessment
A real-world data (RWD) provider wanted to identify key use cases, unmet needs, and future opportunities in the RWD market, with a particular focus on clinical, genomic, and pathology RWD and biopharma users.
Voice-Of-Customer Research
Pricing Strategy
Careers

Become a DeciBion

Our team is multi-faceted but united by the "decibionic" energy that drives us to transform the precision medicine field.

Start Here

Precision Medicine is evolving at a rapid pace

Discover how we can help

Contact Us
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Customer love

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nunc dignissim, mi et varius malesuada Lorem ipsum dolor sit amet, consectetur adipiscing elit.

Precision Medicine. Precision Insights.
© DeciBio 2022. All rights reserved.
Privacy | Terms & Conditions